Australian biotech Microbio has had their InfectID-COVID-19 tests approved for sale in Europe. A revolutionary pathogen identification test, InfectID is a rapid, highly sensitive and adaptable test which addresses different target pathogens. Two SARS-CoV-2 tests by Microbio have been developed and received approval for sale in Europe under IVD Directive 98/79/EC. This approval enables the privately held scale-up to move into additional international markets, including India, North America, Africa, and Asia. The tests have a 100% success rate and have been compared to other real-time Polymerase Chain Reaction
(PCR) tests that claim to detect all variants. | shorturl.at/zFMNY
You’ve probably never heard of intrathecal care. It’s a new drug-delivery method used by palliative care specialists in which a catheter is inserted near the spinal cord, similar to an epidural. It enables pain relief while allowing mobility and lucidity.
This kind of medical advance changes the game on end-of-life care.
The Australian Medical Association estimates it would cost about an extra $275 million a year to make quality supportive care available to all terminally ill Australians who need it. It’s expensive, but certainly possible. It’s a choice that a progressive government could and should make.
The Journal of Emergency Medicine Australasia has published a simple technique to save shark attack victims at the scene by stemming blood loss. The technique relies on a second person using their fist and bodyweight to stem flow in the victim’s groin, buying them time while help arrives. Lead author and surfer, Dr Nicholas Taylor, developed the idea after visiting Western Australia during a time of increased shark attacks. He would like to see the technique incorporated into first aid training. | https://www.theguardian.com/science/2021/sep/24/doctors-brilliant-new-first-aid-technique-can-stem-blood-loss-after-shark-attack
